Decorin-TGFβ Axis in Hepatic Fibrosis and Cirrhosis

Journal of Histochemistry and Cytochemistry

Volumn 60, Issue 4, 2012, Pages 262-268

  Baghy, Kornélia ^a   Iozzo, Renato V ^b   Kovalszky, Ilona ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

decorin; extracellular matrix; hepatic stellate cells; liver fibrosis; small leucine rich proteoglycan; TGF 1

Indexed keywords

DECORIN; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA2;

ABLATION THERAPY; ARTICLE; CELL ACTIVATION; FIBROGENESIS; HEALTH CARE; HEPATITIS; HUMAN; INFORMATION PROCESSING; LIVER CIRRHOSIS; LIVER FIBROSIS; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; STELLATE CELL;

ANIMALS; DECORIN; HUMANS; LIVER CIRRHOSIS; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 84864796944     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155412438104     Document Type: Article

References (60)

1. Akool el S,Doller A,Muller R,Gutwein P,Xin C,Huwiler A,Pfeilschifter J,Eberhardt W.Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.J Biol Chem. 2005;280:39403-39416.
2. Albillos Martinez A.What is the treatment of choice in a patient with liver cirrhosis and esophageal varices that have bled to prevent rebleeding: beta-blockers, endoscopic ligation or both?.Gastroenterol Hepatol. 2009;32:124-125.
3. Al Haj Zen A,Lafont A,Durand E,Brasselet C,Lemarchand P,Godeau G,Gogly B.Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts.Matrix Biol. 2003;22:251-258.
4. Ameye L,Young MF.Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases.Glycobiology. 2002;12 (9): 107R-1016R.
5. Baghy K,Dezso K,Laszlo V,Fullar A,Peterfia B,Paku S,Nagy P,Schaff Z,Iozzo RV,Kovalszky I.Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice.Lab Invest. 2011;91:439-451.
6. Balsano C,Alisi A,Nobili V.Liver fibrosis and therapeutic strategies: the goal for improving metabolism.Curr Drug Targets. 2009;10:505-512.
7. Border WA,Noble NA.Transforming growth factor beta in tissue fibrosis.N Engl J Med. 1994;331:1286-1292.
8. Breitkopf K,Haas S,Wiercinska E,Singer MV,Dooley S.Anti-TGF-beta strategies for the treatment of chronic liver disease.Alcohol Clin Exp Res. 2005;29:121S-131S.
9. Clouthier DE,Comerford SA,Hammer RE.Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.J Clin Invest. 1997;100:697-713.
10. Csordas G,Santra M,Reed CC,Eichstetter I,McQuillan DJ,Gross D,Nugent MA,Hajnoczky G,Iozzo RV.Sustained down-regulation of the epidermal growth factor receptor by decorin: a mechanism for controlling tumor growth in vivo.J Biol Chem. 2000;275:32879-32887.
11. Danielson KG,Baribault H,Holmes DF,Graham H,Kadler KE,Iozzo RV.Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.J Cell Biol. 1997;136:729-743.
12. De Bleser PJ,Niki T,Rogiers V,Geerts A.Transforming growth factor-beta gene expression in normal and fibrotic rat liver.J Hepatol. 1997;26:886-893.
13. Dordrecht (NL): Kluwer Academic Publishers. Desmet VJ, ed. 1992:27-44.
14. Dong FQ,Li H,Wu F,Yao HP.Effects of overexpression of decorin on matrix metalloproteinases 2 and 9 in rat mesangial and tubular cells.Zhonghua Yi Xue Za Zhi. 2008;88:3444-3447.
15. Droguett R,Cabello-Verrugio C,Riquelme C,Brandan E.Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.Matrix Biol. 2006;25:332-341.
16. Dudas J,Kovalszky I,Gallai M,Nagy JO,Schaff Z,Knittel T,Mehde M,Neubauer K,Szalay F,Ramadori G.Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis.Am J Clin Pathol. 2001;115:725-735.
17. El-Gamel A,Awad MR,Hasleton PS,Yonan NA,Hutchinson JA,Campbell CS,Rahman AH,Deiraniya AK,Sinnott PJ,Hutchinson IV.Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis.J Heart Lung Transplant. 1999;18:517-523.
18. Epple A,Kuhn HA,Leveringhaus M,Liehr H.Etiology, complications and prognosis of liver cirrhosis in 917 patients: II. Causes of death and prognosis in liver cirrhosis.Lebensversicher Med. 1979;31:117-122.
19. Fartoux L,Serfaty L.Liver cirrhosis in adults: etiology and specific treatments.Rev Prat. 2005;55:1539-1548.
20. Fiedler LR,Schonherr E,Waddington R,Niland S,Seidler DG,Aeschlimann D,Eble JA.Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity.J Biol Chem. 2008;283:17406-17415.
21. Fischer JW,Kinsella MG,Levkau B,Clowes AW,Wight TN.Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors.Arterioscler Thromb Vasc Biol. 2001;21:777-784.
22. Flanders KC.Smad3 as a mediator of the fibrotic response.Int J Exp Pathol. 2004;85:47-64.
23. Friedman SL.Liver fibrosis: from bench to bedside.J Hepatol. 2003;38 Suppl 1:S38-S53.
24. Garcia-Tsao G,Lim JK.Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.Am J Gastroenterol. 2009;104:1894.
25. Gauldie J,Bonniaud P,Sime P,Ask K,Kolb M.TGF-beta, Smad3 and the process of progressive fibrosis.Biochem Soc Trans. 2007;35:661-664.
26. Goldoni S,Humphries A,Nystrom A,Sattar S,Owens RT,McQuillan DJ,Ireton K,Iozzo RV.Decorin is a novel antagonistic ligand of the Met receptor.J Cell Biol. 2009;185:743-754.
27. Gressner AM.Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.Kidney Int. 1996;54 Suppl:S39-S45.
28. Huijun W,Long C,Zhigang Z,Feng J,Muyi G.Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.Exp Mol Pathol. 2005;78:17-24.
29. Iozzo RV.The biology of the small leucine-rich proteoglycans: functional network of interactive proteins.J Biol Chem. 1999;274:18843-18846.
30. Iozzo RV,Moscatello DK,McQuillan DJ,Eichstetter I.Decorin is a biological ligand for the epidermal growth factor receptor.J Biol Chem. 1999;274:4489-4492.
31. Isaka Y,Brees DK,Ikegaya K,Kaneda Y,Imai E,Noble NA,Border WA.Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.Nat Med. 1996;2:418-423.
32. Kahari VM,Larjava H,Uitto J.Differential regulation of extracellular matrix proteoglycan (PG) gene expression: transforming growth factor-beta 1 up-regulates biglycan (PGI) and versican (large fibroblast PG), but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture.J Biol Chem. 1991;266:10608-10615.
33. Kanzler S,Lohse AW,Keil A,Henninger J,Dienes HP,Schirmacher P,Rose-John S,zum Buschenfelde KH,Blessing M.TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol. 1999;276:G1059-G1068.
34. Kato I,Tominaga S,Ikari A.The risk and predictive factors for developing liver cancer among patients with decompensated liver cirrhosis.Jpn J Clin Oncol. 1992;22:278-285.
35. Knittel T,Kobold D,Saile B,Grundmann A,Neubauer K,Piscaglia F,Ramadori G.Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential.Gastroenterology. 1999;117:1205-1221.
36. Kutz SM,Hordines J,McKeown-Longo PJ,Higgins PJ.TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion.J Cell Sci. 2001;114:3905-3914.
37. Latella G,Vetuschi A,Sferra R,Catitti V,D'Angelo A,Zanninelli G,Flanders KC,Gaudio E.Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.Liver Int. 2009;29:997-1009.
38. La Vecchia C,Negri E,Cavalieri d'Oro L,Franceschi S.Liver cirrhosis and the risk of primary liver cancer.Eur J Cancer Prev. 1998;7:315-320.
39. Massague J.TGF-beta signal transduction.Annu Rev Biochem. 1998;67:753-791.
40. Merline R,Lazaroski S,Babelova A,Tsalastra-Greul W,Pfeilschifter J,Schluter KD,Gunther A,Iozzo RV,Schaefer RM,Schaefer L.Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration.J Physiol Pharmacol. 2009;60 Suppl 4:5-13.
41. Miyazono K,ten Dijke P,Heldin CH.TGF-beta signaling by Smad proteins.Adv Immunol. 2000;75:115-157.
42. Pannu J,Nakerakanti S,Smith E,ten Dijke P,Trojanowska M.Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.J Biol Chem. 2007;282:10405-10413.
43. Popper H.Pathologic aspects of cirrhosis: a review. Am J Pathol. 1977;87:228-264.
44. Reed CC,Gauldie J,Iozzo RV.Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin.Oncogene. 2002;21:3688-3695.
45. Santra M,Reed CC,Iozzo RV.Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope.J Biol Chem. 2002;277:35671-35681.
46. Schaefer L,Iozzo RV.Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction.J Biol Chem. 2008;283:21305-21309.
47. Schaefer L,Tsalastra W,Babelova A,Baliova M,Minnerup J,Sorokin L,Grone HJ,Reinhardt DP,Pfeilschifter J,Iozzo RV, et al.Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin.Am J Pathol. 2007;170:301-315.
48. Schmidt A,Lorkowski S,Seidler D,Breithardt G,Buddecke E.TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC.Eur J Clin Invest. 2006;36:473-482.
49. Schnabl B,Kweon YO,Frederick JP,Wang XF,Rippe RA,Brenner DA.The role of Smad3 in mediating mouse hepatic stellate cell activation.Hepatology. 2001;34:89-100.
50. Schnaper HW.Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis.Pediatr Nephrol. 1995;9:104-111.
51. Schonherr E,Sunderkotter C,Iozzo RV,Schaefer L.Decorin, a novel player in the insulin-like growth factor system.J Biol Chem. 2005;280:15767-15772.
52. Shek FW,Benyon RC.How can transforming growth factor beta be targeted usefully to combat liver fibrosis?.Eur J Gastroenterol Hepatol. 2004;16:123-126.
53. Shi YF,Zhang Q,Cheung PY,Shi L,Fong CC,Zhang Y,Tzang CH,Chan BP,Fong WF,Chun J, et al.Effects of rhDecorin on TGF-beta1 induced human hepatic stellate cells LX-2 activation.Biochim Biophys Acta. 2006;1760:1587-1595.
54. Vallet-Pichard A,Mallet V,Costentin CE,Pol S.Treatment of HBV-related cirrhosis.Expert Rev Anti Infect Ther. 2009;7:527-535.
55. Wang H,Mengsteab S,Tag CG,Gao CF,Hellerbrand C,Lammert F,Gressner AM,Weiskirchen R.Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.World J Gastroenterol. 2005;11:1929-1936.
56. Weber IT,Harrison RW,Iozzo RV.Model structure of decorin and implications for collagen fibrillogenesis.J Biol Chem. 1996;271:31767-31770.
57. Yamaguchi Y,Mann DM,Ruoslahti E.Negative regulation of transforming growth factor-beta by the proteoglycan decorin.Nature. 1990;346:281-284.
58. Zhang G,Ezura Y,Chervoneva I,Robinson PS,Beason DP,Carine ET,Soslowsky LJ,Iozzo RV,Birk DE.Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development.J Cell Biochem. 2006;98:1436-1449.
59. Zhang YE.Non-Smad pathways in TGF-beta signaling.Cell Res. 2009;19:128-139.
60. Zhang Z,Li XJ,Liu Y,Zhang X,Li YY,Xu WS.Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.Burns. 2007;33:634-641.